Literature DB >> 7690108

Involvement of nitric oxide in basal and interleukin-1 beta-induced CRH and ACTH release in vitro.

L Brunetti1, P Preziosi, E Ragazzoni, M Vacca.   

Abstract

NG-Nitro-L-arginine, an inhibitor of nitric oxide synthase, does not influence CRH basal release but is able to modify ACTH basal secretion and to block interleukin-1 beta-induced CRH and ACTH release from rat hypothalamic and anterior pituitary cell cultures in vitro. The data suggest a different involvement of NO at hypothalamic and pituitary level.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7690108     DOI： 10.1016/0024-3205(93)90267-7

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Intercellular interactions in the anterior pituitary.

Authors:  J Schwartz; F M Perez
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

2.  Ascorbic acid acts as an inhibitory transmitter in the hypothalamus to inhibit stimulated luteinizing hormone-releasing hormone release by scavenging nitric oxide.

Authors:  S Karanth; W H Yu; A Walczewska; C Mastronardi; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  Selective inhibitors of nitric oxide synthase (NOS) implicate a constitutive isoform of NOS in the regulation of interleukin-1-induced ACTH secretion in rats.

Authors:  A V Turnbull; C Rivier
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

4.  Biogenesis of regulated exocytotic carriers in neuroendocrine cells.

Authors:  B A Eaton; M Haugwitz; D Lau; H P Moore
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

5.  Nitric oxide stimulates growth hormone secretion from human fetal pituitaries and cultured pituitary adenomas.

Authors:  Tami Rubinek; Hadara Rubinfeld; Moshe Hadani; Gad Barkai; Ilan Shimon
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.